A new hope in immunotherapy against cancer

by Karolinska InstitutetIdentification of SB02024 as a potent and selective inhibitor of VPS34. (A) Chemical structure of SB02024. (B) Cartoon representation of the structure of complex between V

Updated on: April 06,2024

A new hope in immunotherapy against cancer

by Karolinska InstitutetIdentification of SB02024 as a potent and selective inhibitor of VPS34. (A) Chemical structure of SB02024. (B) Cartoon representation of the structure of complex between V

Updated on:April 06,2024

Boosting immune system in chronic myeloid leukemia may lead to discontinuation of blood cancer drugs

by University of HelsinkiSchematics showing the overview of data sets, analysis, and validation and extensions. Picture created with biorender.com. Credit:Leukemia(2023). DOI: 10.1038

Updated on: April 18,2024

Boosting immune system in chronic myeloid leukemia may lead to discontinuation of blood cancer drugs

by University of HelsinkiSchematics showing the overview of data sets, analysis, and validation and extensions. Picture created with biorender.com. Credit:Leukemia(2023). DOI: 10.1038

Updated on:April 18,2024

Just bad luck? Australian cancer patients nominate 'fate' as third most likely cause

by University of South AustraliaCredit: CC0 Public DomainWhat role does fate play when it comes to the 145,000 people diagnosed with cancer each year in Australia?Smoking, sun exposure,poor

Updated on: April 10,2024

Just bad luck? Australian cancer patients nominate 'fate' as third most likely cause

by University of South AustraliaCredit: CC0 Public DomainWhat role does fate play when it comes to the 145,000 people diagnosed with cancer each year in Australia?Smoking, sun exposure,poor

Updated on:April 10,2024

'Bet hedging' explains the efficacy of many combination cancer therapies

by Harvard Medical SchoolKiller T cells surround a cancer cell. Credit: NIHThe efficacy of many FDA-approved cancer drug combinations is not due to synergistic interactions between drugs, but rat

Updated on: March 14,2024

'Bet hedging' explains the efficacy of many combination cancer therapies

by Harvard Medical SchoolKiller T cells surround a cancer cell. Credit: NIHThe efficacy of many FDA-approved cancer drug combinations is not due to synergistic interactions between drugs, but rat

Updated on:March 14,2024

ACS sets goal to cut cancer mortality 40 percent by 2035

(HealthDay)—The American Cancer Society (ACS) has set a goal of a 40 percent reduction in overall cancer mortality by 2035, according to a study published online May 8 inCA: A Cancer Journal for

Updated on: March 27,2024

ACS sets goal to cut cancer mortality 40 percent by 2035

(HealthDay)—The American Cancer Society (ACS) has set a goal of a 40 percent reduction in overall cancer mortality by 2035, according to a study published online May 8 inCA: A Cancer Journal for

Updated on:March 27,2024

'Junk DNA' affects inherited cancer risk

by Cancer Research UKCredit: CC0 Public DomainA person's risk of developing cancer is affected by genetic variations in regions of DNA that don't code for proteins, previously dismissed a

Updated on: March 13,2024

'Junk DNA' affects inherited cancer risk

by Cancer Research UKCredit: CC0 Public DomainA person's risk of developing cancer is affected by genetic variations in regions of DNA that don't code for proteins, previously dismissed a

Updated on:March 13,2024

Simulating your cancer treatment on a computer

by University of OsloArnoldo Frigessi is the main person behind the new idea of making tens of thousands of virtual copies of the individual cancer patient and then testing all the treatments in

Updated on: April 23,2024

Simulating your cancer treatment on a computer

by University of OsloArnoldo Frigessi is the main person behind the new idea of making tens of thousands of virtual copies of the individual cancer patient and then testing all the treatments in

Updated on:April 23,2024

Incidence of cutaneous T-cell lymphoma up in the U.S.

The overall incidence of cutaneous T-cell lymphoma (CTCL) increased in the United States from 2000 to 2018, according to a research letter published online Sept. 1 inJAMA Oncology.Zhuo Ran Cai,

Updated on: January 02,2024

Incidence of cutaneous T-cell lymphoma up in the U.S.

The overall incidence of cutaneous T-cell lymphoma (CTCL) increased in the United States from 2000 to 2018, according to a research letter published online Sept. 1 inJAMA Oncology.Zhuo Ran Cai,

Updated on:January 02,2024

Study finds outcomes after stem cell transplant in elderly patients with AML have improved since 2000

by American Association for Cancer ResearchCredit: CC0 Public DomainAccording to astudypublished inClinical Cancer Research, among patients over 65 who received an allogeneic he

Updated on: March 30,2024

Study finds outcomes after stem cell transplant in elderly patients with AML have improved since 2000

by American Association for Cancer ResearchCredit: CC0 Public DomainAccording to astudypublished inClinical Cancer Research, among patients over 65 who received an allogeneic he

Updated on:March 30,2024

New cell death mechanism could offer novel cancer treatment strategies

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainA study from researchers at The University of Texas MD Anderson Cancer Center, published today inNature C

Updated on: January 12,2024

New cell death mechanism could offer novel cancer treatment strategies

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainA study from researchers at The University of Texas MD Anderson Cancer Center, published today inNature C

Updated on:January 12,2024

Oncology therapy at the end-of-life: Have we missed the mark?

by Yale Cancer CenterCredit:JAMA Oncology(2022). DOI: 10.1001/jamaoncol.2022.4666Continued treatment for patients with cancer near end-of-life delays conversations about goals of care and

Updated on: January 04,2024

Oncology therapy at the end-of-life: Have we missed the mark?

by Yale Cancer CenterCredit:JAMA Oncology(2022). DOI: 10.1001/jamaoncol.2022.4666Continued treatment for patients with cancer near end-of-life delays conversations about goals of care and

Updated on:January 04,2024

Glass filters developed to separate tumor cells from blood may increase efficiency of blood tests for cancer

by Nagoya UniversityThe experimental setup to capture CTCs and CAFs. (a) Schematic of the experimental setup to capture CTCs and CAFs. (b) Photograph of the experimental setup around the glass fi

Updated on: January 30,2024

Glass filters developed to separate tumor cells from blood may increase efficiency of blood tests for cancer

by Nagoya UniversityThe experimental setup to capture CTCs and CAFs. (a) Schematic of the experimental setup to capture CTCs and CAFs. (b) Photograph of the experimental setup around the glass fi

Updated on:January 30,2024